ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Next Science Limited

Next Science Limited (NXS)

0.12
0.00
(0.00%)
Closed December 26 12:00AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.12
Bid
0.115
Ask
0.12
Volume
6,482
0.115 Day's Range 0.12
0.105 52 Week Range 0.50
Market Cap
Previous Close
0.12
Open
0.115
Last Trade
6
@
0.12
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
233,921
Shares Outstanding
291,695,103
Dividend Yield
-
PE Ratio
-2.15
Earnings Per Share (EPS)
-0.06
Revenue
22.28M
Net Profit
-16.27M

About Next Science Limited

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Sydney, New South Wales, Aus
Founded
-
Next Science Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker NXS. The last closing price for Next Science was AUD0.12. Over the last year, Next Science shares have traded in a share price range of AUD 0.105 to AUD 0.50.

Next Science currently has 291,695,103 shares outstanding. The market capitalization of Next Science is AUD35 million. Next Science has a price to earnings ratio (PE ratio) of -2.15.

NXS Latest News

Next Science to Exhibit Surgical Product Portfolio at AAOS 2021

Next Science Limited (ASX:NXS), an innovative medical technology company, announced that it will exhibit at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting and conference in...

Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution

Highlights Clinical trial for XPERIENCE commences after receiving FDA clearance in April Randomized, controlled, double-blinded study will evaluate the effects of XPERIENCE in decreasing surgical...

Next Science Product Featured in Lifetime Channel Program on Treating Chronic Wounds

“The Balancing Act” segment will highlight how Next Science’s BLASTX® non-toxic, antimicrobial wound gel can help heal diabetic ulcers Next Science (ASX:NXS), an innovative medical technology...

Next Science’s XPERIENCE No Rinse Antimicrobial Solution Cleared by FDA for Sale in USA

Highlights XPERIENCE No Rinse Antimicrobial Solution receives FDA clearance XPERIENCE meets large unmet need – market leading performance in reduction of all tested pathogens Commercial sales in...

Next Science’s XPERIENCE No Rinse Antimicrobial Solution Cleared by FDA for Sale in USA

Highlights XPERIENCE No Rinse Antimicrobial Solution receives FDA clearance XPERIENCE meets large unmet need – market leading performance in reduction of all tested pathogens Commercial sales in...

Next Science and 3M Donate $300,000 of Breakthrough Wound Treatment to Jacksonville-Area Charity

New BlastX donation reaffirms the company’s commitment to healthcare nonprofits and their patients suffering from chronic wounds Next Science (ASX:NXS), an innovative medical technology company...

Next Science and 3M Donate $300,000 of Breakthrough Wound Treatment to New Jersey Nursing Care Facility

Blast X donation is one of several to long-term care facilities to effectively treat chronic wounds Next Science (ASX:NXS), an innovative medical technology company that is the leader in...

UPDATE: Senior Woodside Executive Leaves For Nexus Energy

Woodside Petroleum Ltd. (WPL.AU) has lost its third senior staffer since it changed chief executives last year, with the head of its flagship Pluto gas-export project Lucio Della Martina leaving...

Nexus Says Companies Eyeing Crux Stake; Writes Down Longtom

Nexus Energy Ltd. (NXS.AU) on Wednesday said several large companies have expressed interest in buying part of its share of the Crux gas and liquids joint venture with Royal Dutch Shell PLC (RDSB...

Nexus Energy CEO Expects Crux Equity Selldown In 4-6 Weeks

Nexus Energy Ltd. (NXS.AU) is poised to sell down a stake in its Crux liquids project offshore Western Australia state by next month ahead of officially approving construction of the A$1.78...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.01-7.692307692310.130.130.1053027400.11734622DE
4-0.015-11.11111111110.1350.1450.1051778560.12565236DE
12-0.075-38.46153846150.1950.2250.1052339210.13912386DE
26-0.13-520.250.3050.1051855100.17863224DE
52-0.18-600.30.50.1051555560.2396852DE
156-1.095-90.12345679011.2151.330.1051386630.43737178DE
260-1.735-93.53099730461.8552.760.1051532360.90676524DE

NXS - Frequently Asked Questions (FAQ)

What is the current Next Science share price?
The current share price of Next Science is AUD 0.12
How many Next Science shares are in issue?
Next Science has 291,695,103 shares in issue
What is the market cap of Next Science?
The market capitalisation of Next Science is AUD 35M
What is the 1 year trading range for Next Science share price?
Next Science has traded in the range of AUD 0.105 to AUD 0.50 during the past year
What is the PE ratio of Next Science?
The price to earnings ratio of Next Science is -2.15
What is the cash to sales ratio of Next Science?
The cash to sales ratio of Next Science is 1.57
What is the reporting currency for Next Science?
Next Science reports financial results in USD
What is the latest annual turnover for Next Science?
The latest annual turnover of Next Science is USD 22.28M
What is the latest annual profit for Next Science?
The latest annual profit of Next Science is USD -16.27M
What is the registered address of Next Science?
The registered address for Next Science is LEVEL 14, AUSTRALIA SQUARE, 264-278 GEORGE STREET, SYDNEY, NEW SOUTH WALES, 2000
What is the Next Science website address?
The website address for Next Science is www.nextscience.com/
Which industry sector does Next Science operate in?
Next Science operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HZROHazer Group Limited
AUD 0.015
(50.00%)
52.02k
VMLVital Metals Limited
AUD 0.003
(50.00%)
8.95k
ERAEnergy Resources Of Australia Limited
AUD 0.003
(50.00%)
870.97k
CRIOCritica Ltd
AUD 0.003
(50.00%)
1.16M
APCOAPC Minerals Ltd
AUD 0.003
(50.00%)
137.09k
MGUOMagnum Mining and Exploration Ltd
AUD 0.002
(-60.00%)
500k
SBMSt Barbara Limited
AUD 0.20
(-34.43%)
33.47M
MOMMoab Minerals Ltd
AUD 0.002
(-33.33%)
1.46M
NOVOANovatti Group Limited
AUD 0.003
(-25.00%)
1.08M
EMTeMetals Limited
AUD 0.004
(-20.00%)
4.59k
GCMGreen Critical Minerals Ltd
AUD 0.009
(50.00%)
39.14M
SBMSt Barbara Limited
AUD 0.20
(-34.43%)
33.47M
RGLRiversgold Ltd
AUD 0.004
(33.33%)
26.01M
SYASayona Mining Limited
AUD 0.026
(-1.89%)
23.95M
BRNBrainchip Holdings Ltd
AUD 0.315
(5.88%)
22.69M

Discussion

View Full Feed
tw0122 tw0122 4 minutes ago
🦅 🦅 
QMCO
 stock king 1 stock king 1 4 minutes ago
Did they arrest JK yet ..
VXIT
tw0122 tw0122 4 minutes ago
Low floating Eagle has landed another score QMCO $65 + 40%
QMCO
Dodger1 Dodger1 5 minutes ago
https

://www.youtube.com/watch?v=r44Ach4mXE4

Go $AABB
AABB
gapole gapole 5 minutes ago
QMCO hit $66 and more lava coming
QMCO
gp22 gp22 5 minutes ago
$ASST: Same crew that has launched dozens of nanofloat & microfloat orbit shots out of Discord/Robinhood are on $ASST now...Im in more...Those folks can really light em.
ASST
gp22 gp22 5 minutes ago
$ASST: Same crew that has launched dozens of nanofloat & microfloat orbit shots out of Discord/Robinhood are on $ASST now...Im in more...Those folks can really light em.
ASST
manibiotech manibiotech 5 minutes ago
And how many decades??
NWBO
manibiotech manibiotech 6 minutes ago
Exactly
NWBO
EpicNavigator33 EpicNavigator33 6 minutes ago
Ahhh nevermind I am blind
HMBL
nfrequent nfrequent 6 minutes ago
I can't think of a single reason why Lagan would not be planning to merge INQR and FOXO Labs under an OTC symbol and merge RNVA with the FOXO parent under a NYSE AMEX symbol. I see maybe two different ways he might get there, but I think that's where we're going. I could be wrong, but it's logical.
FOXO INQR RNVA
trender18 trender18 6 minutes ago
Ben Quick also owns 26 shares of series A preferred stock. Convertible into 260 million shares.
NFTM
Zadie420 Zadie420 6 minutes ago
These trials were based on mice study. I guess the next PH would be I/II on human. How many trials? who knows.........
NWBO
tw0122 tw0122 6 minutes ago
$6 + 200% cash out casino time for sure 
BCG
AugustaFriends AugustaFriends 6 minutes ago
$ABAT 3.49 next push we break $4.00 maybe the first target tomorrow TARGET $5.60 with the bigger target $10 -$11 in early 2025. Would be sweet if it came before 2025.
ABAT
Implanting Implanting 6 minutes ago
I want to address another issue Dan talked about in this last webinar. I don't think it was discussed here.

That being the issue of the progress of the Springpole EA in 2025. Dan discussed it in some length in the webinar and IMO he may have said something that could tell us when we m
FFMGF
AJH92 AJH92 7 minutes ago
$PSRU Portfolio of Companies / Partnerships

$PSRU is a multi-sector corporation leveraging innovation, asset-backed ventures and strategic partnerships [source: PR December 12, 2024]

African Cinema Content In USA
America's Next Investment (ANI)
Cote Quest
PSRU
Rambo Rell Rambo Rell 7 minutes ago
$ILLR Breaking Into a Billion-Dollar Industry
🌍 This company is entering a $1B+ market with an innovative solution that competitors haven’t caught up to yet. Early investors stand to gain the most as the adoption curve accelerates. Time to act!
ILLR
Rambo Rell Rambo Rell 7 minutes ago
$ILLR Breaking Into a Billion-Dollar Industry
🌍 This company is entering a $1B+ market with an innovative solution that competitors haven’t caught up to yet. Early investors stand to gain the most as the adoption curve accelerates. Time to act!
ILLR
tw0122 tw0122 7 minutes ago
Gets out before next halt $5.30s
BCG
SC8 SC8 7 minutes ago
Please, off course I'm denying that 5 patients have been successfully treated with Radiogel, as the outcomes won't be known for some time, likely years. These weren't early detected primary solid tumors where some results will be know quickly. For these patients, their cancers have already spread
RDGL
Rambo Rell Rambo Rell 7 minutes ago
$ILLR Rebound Potential
📉 Oversold rebound: This stock has been beaten down, but the fundamentals haven’t changed. A sharp rebound could be just around the corner for those bold enough to buy the dip.
ILLR
Rambo Rell Rambo Rell 7 minutes ago
$ILLR Rebound Potential
📉 Oversold rebound: This stock has been beaten down, but the fundamentals haven’t changed. A sharp rebound could be just around the corner for those bold enough to buy the dip.
ILLR
Investor082 Investor082 7 minutes ago
Still expect non dilutive funding from Big Pharma, Flip? No wonder you didn’t take my bet!
NWBO
dombono dombono 7 minutes ago
Thank you for the tip. I've dealt with Edward Jones 25 years ago. Found them to be fair. If you are still dealing with them can you answer a few questions.
Do you know what they charge for a sell?
Is their a minimum amount you have to maintain in your account?
Apprecia
WBSR

Your Recent History

Delayed Upgrade Clock